-
Holding Off on Treatment
Patients diagnosed with low-risk prostate cancer are increasingly opting against immediate surgery or radiation in favor of regularly monitoring their disease.
by Jon Kelvey
-
Healthy Habits
Unhealthy ProcessEating ultraprocessed foods may be linked to an increased risk of certain cancers.
by Kendall Morgan
-
Young Colorectal Cancer Patients Are Often Misdiagnosed
A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
by Bradley Jones
-
From the Editor-in-Chief
Synthetic Lethality and Cancer: Aiming an Arrow at Achilles’ HeelInsights about synthetic lethality have been used to develop cancer treatments.
by William G. Nelson, MD, PhD
-
Recognizing AI’s Potential
Pathologists and radiologists are leading the way in the use of artificial intelligence (AI) to find and track cancer. Machine learning could lay the foundation for using AI more broadly to advance cancer diagnosis and choice of treatment.
by Stephen Ornes
-
Policy Matters
Putting an End to Cancer Health DisparitiesCancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap.
by Michael A. Caligiuri, MD
-
Forward Look
From Cold Virus to Cancer FighterNeurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.
by Sue Rochman
-
Making Clinical Trials More Inclusive
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
-
Forward Look
Opening Clinical Trials to HIV-Positive Cancer PatientsIncluding patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility.
by Andy Kopsa
-
Forward Look
Lung Cancer Biology Differs by Race, Study ShowsResearch findings could help improve personalized treatments for lung cancer patients.
by Stephen Ornes
Cancer Talk
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
